| Q2 2024 |
489 |
$667M |
+$81.5M |
-$67.4M |
+$14.2M |
FTCS, CDC, FEX, AAPL, STIP
|
13F-HR |
7/12/2024, 12:29 PM |
| Q1 2024 |
480 |
$653M |
+$73.1M |
-$210M |
-$137M |
FTCS, CDC, FEX, STIP, FVD
|
13F-HR |
5/10/2024, 12:24 PM |
| Q4 2023 |
492 |
$745M |
+$350M |
-$131M |
+$218M |
FTCS, CDC, STIP, FEX, QQQ
|
13F-HR |
2/5/2024, 11:39 AM |
| Q3 2023 |
441 |
$428M |
+$53.6M |
-$225M |
-$171M |
CDC, CFO, FEX, FVD, CFA
|
Restatement |
11/20/2023, 03:32 PM |
| Q2 2023 |
424 |
$622M |
+$115M |
-$37.6M |
+$77.5M |
CDC, CFO, FEX, BIL, AAPL
|
13F-HR |
8/2/2023, 12:09 PM |
| Q1 2023 |
396 |
$609M |
+$91.6M |
-$20.7M |
+$70.8M |
CDC, CFO, FTCS, BIL, FEX
|
13F-HR |
5/5/2023, 11:38 AM |
| Q4 2022 |
303 |
$533M |
+$106M |
-$37.2M |
+$68.9M |
CFO, CDC, BIL, FTCS, FEX
|
13F-HR |
2/2/2023, 12:56 PM |
| Q3 2022 |
301 |
$299M |
|
|
|
CDC, FEX, FVD, CFA, RDVY
|
Restatement |
10/23/2023, 02:34 PM |
| Q2 2022 |
270 |
$385M |
+$87.9M |
-$40.5M |
+$47.4M |
CDC, FTCS, FEX, TIP, AAPL
|
13F-HR |
8/15/2022, 02:14 PM |
| Q1 2022 |
300 |
$439M |
|
|
|
CDC, FTCS, FEX, TIP, AAPL
|
13F-HR |
5/10/2022, 09:56 AM |